Jim Cramer Says “CRISPR (CRSP) Keeps Losing Money Like Moderna” – Here’s Why

Insider Monkey01-31

We recently published a list of 9 Stocks Jim Cramer Talked About. In this article, we are going to take a look at where CRISPR Therapeutics AG (NASDAQ:CRSP) stands against other stocks that Jim Cramer...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2507674181?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-01-31 02:50","share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","id":"2507674181","market":"us","top_or_hot":-1,"title":"Jim Cramer Says “CRISPR (CRSP) Keeps Losing Money Like Moderna” – Here’s Why","media":"Insider Monkey","content":"<div>\n<p>We recently published a list of 9 Stocks Jim Cramer Talked About. In this article, we are going to take a look at where CRISPR Therapeutics AG (NASDAQ:CRSP) stands against other stocks that Jim Cramer...</p>\n\n<a href=\"https://finance.yahoo.com/news/jim-cramer-says-crispr-crsp-185044079.html\">Source Link</a>\n\n</div>\n","source":"yahoofinance","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Jim Cramer Says “CRISPR (CRSP) Keeps Losing Money Like Moderna” – Here’s Why</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJim Cramer Says “CRISPR (CRSP) Keeps Losing Money Like Moderna” – Here’s Why\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-01-31 02:50 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/jim-cramer-says-crispr-crsp-185044079.html><strong>Insider Monkey</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>We recently published a list of 9 Stocks Jim Cramer Talked About. In this article, we are going to take a look at where CRISPR Therapeutics AG (NASDAQ:CRSP) stands against other stocks that Jim Cramer...</p>\n\n<a href=\"https://finance.yahoo.com/news/jim-cramer-says-crispr-crsp-185044079.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":null,"symbol_name":null,"start_time":0,"source_url":"https://finance.yahoo.com/news/jim-cramer-says-crispr-crsp-185044079.html","article_id":"2507674181","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2507674181","pubTimestamp":1738263044,"columns":[],"sourceInfo":{"source_id":"yahoofinance","name":"雅虎金融"},"weMediaInfo":null,"summary":"We recently published a list of 9 Stocks Jim Cramer Talked About. In this article, we are going to take a look at where CRISPR Therapeutics AG  stands against other stocks that Jim Cramer talked about.Jim Cramer, the host of Mad Money, reflected on the uncertainty surrounding the year 2025, focusing on several macroeconomic questions that are top of mind for him. One of the important questions Cramer was the future movement of the 10-year Treasury yield.Specifically, he wondered whether it would drop to 4%, climb to 5%, or simply stay where it is. According to Cramer, this is the most important question currently facing the market. He pointed out that ever since the Federal Reserve began cutting short-term rates in September 2024, an unusual dynamic has taken place.Why are we interested in the stocks that hedge funds pile into?The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{},"translate_title":"Jim Cramer表示“CRISPR(CRSP)像Moderna一样不断亏损”——原因如下","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CRSP":1},"content_text":"We recently published a list of 9 Stocks Jim Cramer Talked About. In this article, we are going to take a look at where CRISPR Therapeutics AG (NASDAQ:CRSP) stands against other stocks that Jim Cramer talked about.\nJim Cramer, the host of Mad Money, reflected on the uncertainty surrounding the year 2025, focusing on several macroeconomic questions that are top of mind for him. One of the important questions Cramer was the future movement of the 10-year Treasury yield.\nSpecifically, he wondered whether it would drop to 4%, climb to 5%, or simply stay where it is. According to Cramer, this is the most important question currently facing the market. He pointed out that ever since the Federal Reserve began cutting short-term rates in September 2024, an unusual dynamic has taken place.\nFrom the moment the first rate cut occurred, long-term interest rates began to rise sharply, a trend Cramer found highly unconventional. Cramer posed the crucial question: will the yield continue to rise toward that 5% mark, or will it begin to fall again?\n\n“As far as stocks are concerned, I think they’ll do well if the yield on the 10-year peaks out and go slower, even if it basically sits here between 4.5% and 4.6%, the market should do fine. However, if long rates keep climbing with the 10-year reaching 5%, well, it could be truly miserable for the stock market at least short term.”\n\nREAD ALSO: Jim Cramer Talked About These 11 Stocks Recently and 7 Stocks on Jim Cramer’s Radar\nAnother critical issue Cramer pondered was the state of the labor market. Despite signs of economic softening in recent months, unemployment remains exceptionally low, which is contributing to a strong overall labor market. According to Cramer, this is the reason many are hopeful for a “soft landing” after the Federal Reserve’s aggressive rate hikes in 2022 and 2023.\n\n“So can the labor market stay strong this year? Right now, I’m betting it can. Remember the labor market was great during the first three years of the original Trump administration. We had 3.5% unemployment right before COVID hit and everything fell apart. Plus, if Trump pushes through mass deportations… it could cause a major labor shortage. If anything, we probably should be worrying about whether the labor market will get too tight, causing severe wage inflation.”\n\nOur Methodology\nFor this article, we compiled a list of 9 stocks that were discussed by Jim Cramer during episodes of Mad Money aired on January 3rd and January 6th. We listed the stocks in ascending order of their hedge fund sentiment as of the third quarter, which was taken from Insider Monkey’s database of 900 hedge funds.\nWhy are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 275% since May 2014, beating its benchmark by 150 percentage points (see more details here).\n\nCRISPR Therapeutics AG (NASDAQ:CRSP)\nNumber of Hedge Fund Holders: 27\nIn response to a caller’s question about CRISPR Therapeutics AG (NASDAQ:CRSP), Cramer said:\n\n“You know, I want to own, I want to own CRISPR because I keep seeing their name come up and all the science papers that I read and I read quite a bit of them, but boy, the stock’s been a tough own. Let’s put some away and then if it goes lower, we’ll buy more. But I, I understand. How could that company keep losing money like this? It is just, it’s Moderna-like… in the money they throw in the chimney.”\n\nCRISPR (NASDAQ:CRSP) develops gene-based medicines using its CRISPR/Cas9 platform, with therapies targeting diseases like hemoglobinopathies, cancer, and type 1 diabetes.\nOverall, CRSP ranks 6th on our list of stocks that Jim Cramer talked about. While we acknowledge the potential of CRSP as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than CRSP but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.\nREAD NEXT: 20 Best AI Stocks To Buy Now and Complete List of 59 AI Companies Under $2 Billion in Market Cap\nDisclosure: None. This article is originally published at Insider Monkey.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.30.2","shortVersion":"4.30.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2507674181"}